Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Shares Outstanding (Diluted Average): 2022-2024

Historic Shares Outstanding (Diluted Average) for Abeona Therapeutics (ABEO) over the last 3 years, with Dec 2024 value amounting to $41.0 million.

  • Abeona Therapeutics' Shares Outstanding (Diluted Average) rose 36.81% to $65.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.8 million, marking a year-over-year increase of 36.81%. This contributed to the annual value of $41.0 million for FY2024, which is 91.99% up from last year.
  • Abeona Therapeutics' Shares Outstanding (Diluted Average) amounted to $41.0 million in FY2024, which was up 91.99% from $21.4 million recorded in FY2023.
  • In the past 5 years, Abeona Therapeutics' Shares Outstanding (Diluted Average) ranged from a high of $41.0 million in FY2024 and a low of $7.9 million during FY2022.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $21.4 million (2023), whereas its average is $23.4 million.
  • Data for Abeona Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY surged of 171.96% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Abeona Therapeutics' Shares Outstanding (Diluted Average) stood at $7.9 million in 2022, then skyrocketed by 171.96% to $21.4 million in 2023, then spiked by 91.99% to $41.0 million in 2024.